Target intelligence / Profile preview

Ambler class A beta-lactamase enzyme (class A β-lactamase)

Target
class A β-lactamase
Molecular classification
Enzyme, Hydrolase, Serine beta-lactamase
01

Overview

Ambler class A beta-lactamase enzymes are a group of serine hydrolase enzymes produced by both Gram-negative and some Gram-positive bacteria that confer resistance to beta-lactam antibiotics, including penicillins, most cephalosporins, and monobactams, by hydrolyzing their characteristic four-membered beta-lactam ring[3][4][5]. Class A beta-lactamases are categorized based on their conserved sequence motifs, structure, and mechanistic features, notably utilizing a catalytic serine residue in the active site[1][5]. Prominent representatives in clinical resistance include TEM, SHV, CTX-M, and KPC subclasses, which are responsible for extended-spectrum beta-lactamase (ESBL) activity and, in some cases, resistance to carbapenems[1][4][5]. These enzymes are a major therapeutic target for beta-lactamase inhibitors in combination antibiotic strategies. The presence of class A beta-lactamases in bacterial pathogens is a key factor in the global crisis of antimicrobial resistance[4][5].

Other names
Class A beta-lactamaseClass A β-lactamaseSerine beta-lactamase class ATEM beta-lactamase (subfamily)SHV beta-lactamase (subfamily)CTX-M beta-lactamase (subfamily)KPC beta-lactamase (subfamily)
02

Mechanism of action

Hydrolyzes the beta-lactam ring of antibiotics, rendering them inactive[3][4]; Some inhibitors form a covalent bond with the catalytic serine to block activity[4]

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam antibiotics
04

Disease associations

InfectionAntimicrobial resistance
05

Safety considerations

Rapid evolution/mutation enabling resistance against newer drugs (including expanded spectrum and carbapenemases within class A)Therapeutic challenge due to limited antibiotic options when present in pathogens[1][4]Potential failure of beta-lactam antibiotics and inhibitors in infections caused by high-level class A beta-lactamase–producing pathogens
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillins, cephalosporins, monobactams)

3 more in the full profile.

07

Biomarkers

Detection of class A beta-lactamase genes or activity in bacterial isolates may be used as a biomarker for resistance (e.g., detection of TEM, SHV, KPC, CTX-M genes by molecular or phenotypic methods)[1][4]ESBL (extended-spectrum beta-lactamase) tests in clinical labs

Beyond the preview

Go deeper on Ambler class A beta-lactamase enzyme (class A β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ambler class A beta-lactamase enzyme (class A β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call